Breast CancerNCT07644845
MammoVerse: Clinicians Focus Group
An observational study of Breast Cancer, run by University of Central Florida at 1 site in United States.
Trial summary
The purpose of this study is to gather insights from clinicians who provide care to women diagnosed with breast cancer in Florida in order to identify gaps in emotional and mental health support encountered throughout the cancer care continuum. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Breast Cancer
- How many people
- 12 participants
- Where
- 1 siteUnited States
- Study dates
- 26 Feb 2026to 31 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Recruitment will be through targeted outreach to clinicians providing breast cancer care in Florida. Invitations will be distributed via email to University of Central Florida College of Medicine UCF COM faculty, affiliated faculty and clinical partners over the recruitment period. Interested clinicians will be provided with study information and instructions for contacting the research team as well as accessing the online consent and enrollment materials. Interested clinicians will enroll online, and provide their information for scheduling the focus group meeting.
Who may be able to join
- they are an adult (over 18)
- physician (MD or DO), licensed psychologist (PhD or PsyD), advanced practice provider (ARNP or PA), nurse (RN or LPN), licensed clinical social worker (LCSW) or other licensed clinician
- provide specialized cancer care to women diagnosed with breast cancer in Florida
- can provide informed consent
- are self-reporting that they licensed clinicians
- are self-reporting that they are physically able to participate in a 60-minute group discussion.
Who cannot join
- This study will NOT include persons under the age of 18, prisoners, and persons unable to speak English fluently, and persons unable to provide informed consent. We are not able to accommodate non-English speakers as this is a pilot study involving group discussion.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
University of Central Florida
Orlando, Florida, 32827
About this study
Official title: MammoVerse: Clinicians Exploring the Gaps for Treatment and Support for Women Breast Cancer Patients in Florida
The purpose of this study is to gather insights from clinicians who provide care to women diagnosed with breast cancer in Florida in order to identify gaps in emotional and mental health support encountered throughout the cancer care continuum. Clinicians will participate in virtual focus group discussions and complete a brief online demographic questionnaire. By capturing clinicians' perspectives on unmet psychosocial needs, barriers to support, and opportunities to improve patient-centered care, this study aims to inform the refinement of MammoVerse, an AI-based digital support platform intended to enhance emotional well-being, peer connection, and healthcare engagement among women facing breast cancer. This study offers preliminary data to inform the development of the MammoVerse AI platform later.
- Conditions
- Breast Cancer
- Keywords
- Oncology, Clinicians, focus group, support
- Medical subject headings
- Breast Neoplasms, Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinician Based Focus Group to assess Emotional and Psychosocial Experiences of Women Diagnosed with Breast Cancer
This focus group study serves as the qualitative foundation for understanding the emotional and psychosocial experiences of women diagnosed with breast cancer from their clinicians' viewpoints. Insights from this exploratory work will guide future quantitative validation and the design of digital psychosocial interventions, such as AI-driven conversational tools, to provide empathetic and contextually relevant emotional support
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jun 2026
- Study start26 Feb 2026
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 12 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Central Florida
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07644845
- Sponsor's protocol ID
- STUDY00008646
- Status last verified
- Jun 2026
- First submitted
- 8 Jun 2026
- Last updated
- 12 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- MammoVerse: Clinicians Exploring the Gaps for Treatment and Support for Women Breast Cancer Patients in Florida
- ClinicalTrials.gov ID
- NCT07644845
- Acronym / sponsor ID
- STUDY00008646
- Conditions
- Breast Cancer
- Keywords
- Oncology, Clinicians, focus group, support
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 12 participants (estimated)
- Lead sponsor
- University of Central FloridaUniversity, hospital or other
- Study start
- 26 Feb 2026 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 12 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to gather insights from clinicians who provide care to women diagnosed with breast cancer in Florida in order to identify gaps in emotional and mental health support encountered throughout the cancer care continuum. Clinicians will participate in virtual focus group discussions and complete a brief online demographic questionnaire. By capturing clinicians' perspectives on unmet psychosocial needs, barriers to support, and opportunities to improve patient-centered care, this study aims to inform the refinement of MammoVerse, an AI-based digital support platform intended to enhance emotional well-being, peer connection, and healthcare engagement among women facing breast cancer. This study offers preliminary data to inform the development of the MammoVerse AI platform later.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Recruitment will be through targeted outreach to clinicians providing breast cancer care in Florida. Invitations will be distributed via email to University of Central Florida College of Medicine UCF COM faculty, affiliated faculty and clinical partners over the recruitment period. Interested clinicians will be provided with study information and instructions for contacting the research team as well as accessing the online consent and enrollment materials. Interested clinicians will enroll online, and provide their information for scheduling the focus group meeting.
Key inclusion criteria (6 listed)
- they are an adult (over 18)
- physician (MD or DO), licensed psychologist (PhD or PsyD), advanced practice provider (ARNP or PA), nurse (RN or LPN), licensed clinical social worker (LCSW) or other licensed clinician
- provide specialized cancer care to women diagnosed with breast cancer in Florida
- can provide informed consent
- are self-reporting that they licensed clinicians
Key exclusion criteria (1 listed)
- This study will NOT include persons under the age of 18, prisoners, and persons unable to speak English fluently, and persons unable to provide informed consent. We are not able to accommodate non-English speakers as this is a pilot study involving group discussion.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Clinician Based Focus Group to assess Emotional and Psychosocial Experiences of Women Diagnosed with Breast Cancer
Time frame: 6 months
This focus group study serves as the qualitative foundation for understanding the emotional and psychosocial experiences of women diagnosed with breast cancer from their clinicians' viewpoints. Insights from this exploratory work will guide future quantitative validation and the design of digital psychosocial interventions, such as AI-driven conversational tools, to provide empathetic and contextually relevant emotional support
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jun 2026.
Related trials for Breast Cancer
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Adjustment Disorder, Adjustment Disorder With Anxious Mood
Recruiting
Evaluation of the Effect of Using Ultrasound Robots for Breast Cancer Screening
Breast Cancer, Ultrasound
RecruitingPhase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Active, not recruiting
Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening
Breast Cancer Female, BRCA1 Mutation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Breast Cancer, run by University of Central Florida at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinician Based Focus Group to assess Emotional and Psychosocial Experiences of Women Diagnosed with Breast Cancer (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026.